Recorded non-cancer comorbidity burden and inpatient service use among cancer-related admissions at a secondary hospital in China, 2014–2025

Abstract Background Evidence on non-cancer chronic comorbidity and inpatient service use among cancer-related admissions to secondary hospitals in China remains limited. This study examined recorded comorbidity patterns and their associations with length of stay (LOS) and hospitalization expenditure at a Chinese secondary hospital. Methods This retrospective observational study included 26,562 adult admissions with an ICD-10 C00–C97 code in any diagnosis field during 2014–2025. Comorbidity burden was measured using 17 selected non-cancer chronic condition categories and grouped as 0, 1, 2, 3, or ≥ 4 conditions. Outcomes included LOS, cumulative inpatient days, and hospitalization expenditure expressed in US dollars at 2025 prices. Negative binomial and gamma-log generalized linear models estimated adjusted mean ratios for LOS and expenditure, respectively, controlling for age, sex, discharge year, cancer diagnosis position, and recorded cancer site group. Sensitivity analyses examined alternative specifications, recent periods, and patient-level clustering. Results Cancer appeared only in secondary diagnosis fields in 85.3% of admissions. Overall, 55.1% had ≥ 1 selected condition and 22.7% had ≥ 2. These proportions increased from 47.6% and 17.5% in 2014 to 62.2% and 29.1% in 2025, respectively, and were higher among older admissions. Hypertension, diabetes, and chronic liver disease were the most commonly recorded conditions. Admissions accounted for 229,888 inpatient days; median LOS was 6 days (IQR, 4–10), and median expenditure was US$810.44 (IQR, 435.76–1,484.68). Admissions with ≥ 2 conditions contributed 25.9% of inpatient days. Higher burden corresponded to longer LOS and higher expenditure in unadjusted comparisons. After adjustment, mean LOS ratios were 1.07 (95% CI, 1.02–1.12) for three conditions and 1.13 (95% CI, 1.02–1.25) for ≥ 4 conditions versus none. Neither comparison met the significance threshold after multiple-testing correction. Adjusted expenditure ratios remained close to 1. In patient-clustered analyses for 2020–2025, all burden-category confidence intervals included 1 for both outcomes. Conclusions Recorded non-cancer chronic conditions were common, and admissions with multiple conditions contributed a greater share of inpatient days than of admissions. Evidence for adjusted LOS differences was limited, and expenditure showed no consistent gradient. These findings provide a local basis for planning integrated cancer and chronic disease care.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11445764/v1
Primary Topic
Chronic Disease Management Strategies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Recorded non-cancer comorbidity burden and inpatient service use among cancer-related admissions at a secondary hospital in China, 2014–2025

Changgui Chen, Yidong Wu, Yuanyuan Li, Hanyue Xu
3 links
Research Square
Chronic Disease Management Strategies
preprint

Recorded non-cancer comorbidity burden and inpatient service use among cancer-related admissions at a secondary hospital in China, 2014–2025

Changgui Chen, Yidong Wu, Yuanyuan Li, Hanyue Xu
preprint en

Abstract

Abstract Background Evidence on non-cancer chronic comorbidity and inpatient service use among cancer-related admissions to secondary hospitals in China remains limited. This study examined recorded comorbidity patterns and their associations with length of stay (LOS) and hospitalization expenditure at a Chinese secondary hospital. Methods This retrospective observational study included 26,562 adult admissions with an ICD-10 C00–C97 code in any diagnosis field during 2014–2025. Comorbidity burden was measured using 17 selected non-cancer chronic condition categories and grouped as 0, 1, 2, 3, or ≥ 4 conditions. Outcomes included LOS, cumulative inpatient days, and hospitalization expenditure expressed in US dollars at 2025 prices. Negative binomial and gamma-log generalized linear models estimated adjusted mean ratios for LOS and expenditure, respectively, controlling for age, sex, discharge year, cancer diagnosis position, and recorded cancer site group. Sensitivity analyses examined alternative specifications, recent periods, and patient-level clustering. Results Cancer appeared only in secondary diagnosis fields in 85.3% of admissions. Overall, 55.1% had ≥ 1 selected condition and 22.7% had ≥ 2. These proportions increased from 47.6% and 17.5% in 2014 to 62.2% and 29.1% in 2025, respectively, and were higher among older admissions. Hypertension, diabetes, and chronic liver disease were the most commonly recorded conditions. Admissions accounted for 229,888 inpatient days; median LOS was 6 days (IQR, 4–10), and median expenditure was US$810.44 (IQR, 435.76–1,484.68). Admissions with ≥ 2 conditions contributed 25.9% of inpatient days. Higher burden corresponded to longer LOS and higher expenditure in unadjusted comparisons. After adjustment, mean LOS ratios were 1.07 (95% CI, 1.02–1.12) for three conditions and 1.13 (95% CI, 1.02–1.25) for ≥ 4 conditions versus none. Neither comparison met the significance threshold after multiple-testing correction. Adjusted expenditure ratios remained close to 1. In patient-clustered analyses for 2020–2025, all burden-category confidence intervals included 1 for both outcomes. Conclusions Recorded non-cancer chronic conditions were common, and admissions with multiple conditions contributed a greater share of inpatient days than of admissions. Evidence for adjusted LOS differences was limited, and expenditure showed no consistent gradient. These findings provide a local basis for planning integrated cancer and chronic disease care.

Research Square
Hangzhou Women’s Hospital (CN), Hangzhou Red Cross Hospital (CN)
Good health and well-being
Chronic Disease Management Strategies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon